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A B S T R A C T
Increased dietary fat intake in general, and saturated fat specifically, will lead to the
impairment of insulin action. The aim of this study was to find out the changes in hepa-
tic glucose output in dependence of fat diet and a possible direct action of insulin and
trogitazone in hepatocytes. Hepatocytes were isolated by a collagenase perfusion tech-
nique and cultured for 24 h in M 199 serum-free medium. The glucose production in he-
patocytes isolated from rats on high fat diet (unsaturated fat) was 79% higher compared
to control and even 139% higher than in rats on high-fat diet (saturated fat). Troglitazo-
ne significantly decreased the glucose production in hepatocytes obtained from rats on
unsaturated fat diet. The troglitazone in presence of insulin totally normalized glucose
production but also only in hepatocytes obtained from rats on unsaturated-fat diet. The
troglitazone showed an insulinomimetic as well as insulin-sensitizing effect but only in
rats on unsaturated-fat diet.
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Introduction
Insulin resistance is a common pheno-
menon in obesity and Type 2 diabetes1. A
high level of dietary fat intake is believed
to be a major factor in the development of
obesity and insulin resistance2. The pat-
hophysiology of Type 2 diabetes involves
characteristic defects in three main organ
systems that conspire together to produce
abnormal glucose metabolism. Metabolic
defects in the liver, the peripheral target
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tissues and the pancreatic -cells all con-
tribute to the syndrome. The enhance-
ment of insulin action might be an effecti-
ve pharmacological approach to diabetes
Type 2. Troglitazone appears to enhance
the insulin action without directly stimu-
lating insulin secretion. This drug may
reduce plasma glucose by facilitating
glycolysis and also by inhibiting gluco-
neogenesis in the liver and this is invol-
ved in the enhancement of insulin action
both in vivo as well as in vitro3–5.
Fat feeding induces insulin resistance
firstly in liver followed by a widespread
impairment of insulin action in white and
brown adipose tissue and skeletal muscle
with early metabolic changes favoring an
oversupply of energy substrate to skeletal
muscle6. The type of dietary fat is thought
to be important in this regard. Increased
dietary fat intake in general, and satura-
ted fat specifically, will lead to increased
adiposity. This increased adiposity, parti-
cularly central adiposity, will lead to the
impairment of insulin action. However,
increased fat intake also appears to lead
to insulin resistance independent of adi-
posity. Again saturated fat, in particular,
would appear to be a major culprit. In-
creased hepatic glucose output correlates
well with fasting glucose levels and is the
main cause of fasting hyperglycemia in
Type 2 diabetes2. We tried to find out if
the increase of hepatic glucose output de-
pends on the percentage of saturated and
unsaturated fat consumed during the
early experimental period before the de-
velopment of manifest diabetes symp-
toms. We measured the rate of glucose
production in hepatocytes isolated from
rats fed with saturated fat of mainly ani-
mal origin and unsaturated fat from sun-
flower oil and we found striking differen-
ces in the rate of glucose production as
well as in the insulin and trogitazone ac-
tion.
Materials and Methods
In all experiments, male adult Wistar
rats, each weighting 187–240 g, were
used. Rats were housed individually in
wire cages in a temperature-controlled
room (21 ± 1 °C), on 12h light-dark cycle,
with free access to food and water for
three weeks. In terms of energy, the stan-
dard food contained 57% carbohydrates,
32% protein and 11% fat. The high-fat
diet was prepared by mixing 30% of sun-
flower oil or 30% of animal fat with stan-
dard food. In both cases the high-fat diet
contained 30% carbohydrates, 16% pro-
tein and 54% fat (Table 1).
The principles of animal care (NIH
publication No. 85–23, revised 1985) we-
re applied.
The hepatocytes were isolated by a mo-
dified collagenase-perfusion technique7.
The rats were anaesthetized with Pheno-
barbital (10 mg/100 g body weight) and
calcium-free Swim’s S-77 medium contai-
ning collagenase (0.5 g/l was used for li-
ver perfusion through a portal cannula.
Usually more than 90% of cells excluded
trypan blue as a measure of viability. Af-
ter washing twice with the same collage-
nase-free medium, the cells were suspen-
ded in a final concentration of one million
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TABLE 1
COMPOSITION OF DIETS
Standard food Sunflower oil 30% Animal fat 30%
Carbohydrates(%of energy) 57 30 30
Protein (% of energy) 32 16 16
Fat (% of energy) 11 54 54
cells per ml M199 serum-free medium.
Three ml of cell suspension were placed
in 60-mm Petri dishes previously coated
with collagen. The culture dishes were
kept at 37 °C in an atmosphere of 5% CO2
and 95% air (CO2 incubator Heraeus, Ha-
nau, Germany). The culture medium was
replaced by a fresh medium 4 hours later
to remove the unattached cells while the
hepatocytes were incubated for the next
24 hours in the M199 serum-free me-
dium.
After having been immersed for 24h in
the culture, the medium was removed
and the cells were incubated in glucose-
free Hanks-Hepes medium, containing 10
mmol/l pyruvate, without hormones (con-
trol), either with insulin (80 nmol/l) or
with troglitazone (2 mg/l). The glucose
production was measured by incubating
the cultures in glucose-free Hanks-Hepes
medium with the addition of 10 mmol/l
pyruvate. The glucose was determined
enzymatically by means of glucose oxida-
se. The incubation medium was removed
and the hepatocytes were washed three
times with cold saline and immediately
frozen in liquid nitrogen. The cells were
digested in 0.2 N NaOH and an aliquot
was taken for the determination of glyco-
gen and protein. The amount of protein
was determined by the Lowry et al. met-
hod8.
Albumin bovine, glutamine, HEPES,
M199 medium, Swim’s S-77 medium, in-
sulin, were obtained from Sigma; collage-
nase CLS II (131U/ mg) was purchased
from Worthington; collagen R was pur-
chased from Serva; troglitazone (Rezulin)
was purchased from Parke-Davis.
Perfusion medium is a Swim’s S-77
medium containing 2.2 g NaHCO3 and
585 mg glutamine per litter.
Incubation medium is a M199 medium
containing the following additions per lit-
ter: 2 g albumen, 900 mg L-glutamine
and 2.2 g NaHCO3.
The data are expressed as means ±
SEM. The statistical significance was
evaluated by Student’s t-test. P<0.01 was
considered statistically significant.
Results
The dietary intake expressed in terms
as gram per day was significantly higher
in rats on standard food compared with
animals on high-fat diet, mostly unsatu-
rated (sunflower oil) as well as in animal
on rendered fat diet (Table 2). There was
no significant difference in energy intake
between the three groups over a 21-day
period. The final body weight was a little,
but not significantly higher in rats on high-
fat diet.
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TABLE 2
METABOLIC CHARACTERISTIC OF RATS IN EACH GROUP
Characteristic Standard food Unsaturated fat 30% Saturated fat 30%
No. of animals 3 3 3
Diet duration (d) 21 21 21
Final body weight (g) 297 + 18* 305 + 24** 309 + 22**
Food intake (g/d) 23,1 + 2* 18,4 + 1,1*** 18,7 + 1,6***
Energy intake (KJ/rat.day) 364 + 31* 430 + 26** 437 + 37**
* Mean + SEM
** Difference from values in group 1, N.S.
*** Difference from values in group 1, p < 0,01
The highest rate of glucose production
in control cultures occurred in the first
hour, whereas a considerably lower rate
was found during the second hour and it
completely stopped in the third hour (Fig-
ure 1). Since these cells were incubated in
glucose-free Hanks-Hepes medium with-
out pyruvate, the glucose production in
control cultures was delivered by quick
activation of glycogenolysis. The highest
rate of glycogenolysis was in the first
hour, whereas a considerably lower rate
was found during the second hour and it
completely stopped in the third hour. In
cultured hepatocytes isolated from the
rats on standard diet, the rate of glucose
production was significantly higher in
the presence of 10 mmol/l pyruvate, com-
pared with the control group. This differ-
ence was the highest in the third hour
(140%) as a result of a strong activation of
gluconeogenesis (Figure 1). The addition
of pyruvate very strongly (427%) increa-
sed the glucose production in hepatocytes
isolated from rats on high-fat (sunflower
oil) diet. There was an almost linear in-
crease in glucose production throughout
the 3-hour period. The increase in glucose
production was even higher (569%) in
cultures isolated from rats on high ani-
mal-fat diet (Figure 1).
The insulin alone, in a concentration
of 80 nmol/l, did not change the glucose
production in hepatocytes isolated from
rats on high-fat (sunflower oil) diet. The
glucose production remained 79% higher
compared with standard cultures (Figure
2). The addition of troglitazone (2 mg/l)
significantly decreased the glucose pro-
duction, but it was still 48% higher than
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Fig. 1. Glucose production (nmol/mg prot) in
cultured hepatocytes incubated in glucose-free
Hanks-Hepes medium without (control) (--) or
in the presence of 10 mmol/l pyruvate, isolated
from rats standard (--), sunflower oil (--) and
animal-fat diet (--). Each point is the mean ±
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Fig. 2. Glucose production (nmol/mg prot) in
cultured hepatocytes incubated in glucose-free
Hanks-Hepes medium in presence 10 mmol/l
pyruvate, isolated from rats on sunflower oil
diet without (--), or treated with insulin (80
nmol/l) (--), or troglitazone (2 mg/l) (--), or
insulin and troglitazone (--) and standard
control (--). Each point is the mean ± SEM for
nine plates in three separate experiments.
in standard cultures. However, troglita-
zone in cultures treated with insulin com-
pletely normalized the glucose production
in the first and second hour of incubation.
Later, during the third hour, the glucose
production was minimally (25%) but sig-
nificantly higher than in standard cultu-
res (Figure 2).
On the other hand, in hepatocytes iso-
lated from rats on high animal fat diet,
the basic glucose production was 139%
higher than in standard cultures. The
insulin only minimally but significantly
decreased this production, but it still re-
mained 103% higher than in standard
cultures. However, troglitazone alone or
in combination with insulin could not
normalize the glucose production and it
remained 114% and 129% higher than in
standard cultures (Figure 3).
Discussion
The present study demonstrates that
the basic glucose production in hepato-
cytes cultured in vitro is highly dependent
on the percentage of fat consumed during
the three-week period in rats. It is also
dependent on the percentage of saturated
fat in diet, independently of adiposity sin-
ce final body weight was not significantly
different at the end of the experiment. A
good deal of evidence has now accumula-
ted to show that the fatty acid profile of
the diet is important. The evidence has
ranged from early in vitro evidence of dif-
ferences in insulin binding and glucose
transport in cells incubated with differ-
ent types of fat or in vivo in animals on
different fat diets9–12. We showed that the
glucose production in hepatocytes isola-
ted from rats on high-fat (sunflower oil)
diet was 79% higher compared with stan-
dard control and even 139% higher in rats
on high-saturated-fat diet. Probably ele-
vated free fatty acids contribute to the in-
creased rates of gluconeogenesis. This is
an important finding because increased
hepatic glucose output correlates well with
fasting glucose levels and is the main
cause of fasting hyperglycemia in Type 2
diabetes2. Hyperglycemia in the early pe-
riod along with elevated free fatty acid le-
vels also contributes to the development
of insulin resistance1,13. Hepatic free fatty
acid oxidation promotes gluconeogenesis
through the production of ATP, NADH,
and acetyl-CoA (to activate pyruvate car-
boxylase) 14.
The failure of insulin to inhibit hepa-
tic glucose production is a cardinal featu-
re of insulin resistance in the liver and a
major factor contributing to hyperglyce-
mia in diabetic states. Developing of in-
sulin resistance could provide a simple
explanation to our results since insulin
did not decrease the glucose production in
hepatocytes in either experimental group.
Some in vivo studies suggested that much
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Fig. 3. Glucose production (nmol/mg prot) in
cultured hepatocytes incubated in glucose-free
Hanks-Hepes medium in the presence of 10
mmol/l pyruvate, isolated from rats on animal
fat diet without (--), or treated with insulin
(80 nmol/l) (--), or troglitazone (2 mg/l) (--),
or insulin and troglitazone (--) and standard
control (--). Each point is the mean ± SEM for
nine plates in three separates experiments.
of insulin action on the liver may be indi-
rect and related to systemic rather than
hepatic insulin effects15,16. We already
showed that insulin does not decrease the
glucose production in hepatocytes isola-
ted from rats on a standard diet and cul-
tured in vitro in a glucose-free medium17.
This result is not so unexpected since,
when insulin is injected into an animal in
vivo, it causes a deep hypoglycemia, which
in turn initiates an intense glycogeno-
lysis in the liver and increases the gluco-
se production18. When blood glucose con-
centration is low in vivo or in glucose-free
medium in vitro, the hepatocytes produce
glucose mainly from glycogen, which was
also demonstrated. The glycogen stores
are limited and get exhausted after one
hour in cultured hepatocytes. The glucose
supply relies then on its synthesis from
non-glucidic precursors such as lactate or
pyruvate. The process of gluconeogenesis
was activated during the first hour of in-
cubation in our experiments, but it beca-
me the main process for glucose produc-
tion during the second and the third hour
and again the insulin could not decrease
the glucose production in a glucose-free
medium. In elegant experiments perfor-
med on LIRKO mice Fisher & Kahn
showed that an intact insulin-signaling
pathway in the liver is required for insu-
lin direct and indirect action on hepatic
glucose production19. So with all these
facts in mind we concluded that insulin
resistance was probably developed during
the three-week period of high-fat feeding.
Thiazolidinediones appear to enhance
the insulin action reducing the insulin re-
sistance. Troglitazone is one of these in-
sulin-sensitizing agents3. Primary tissue
target for troglitazone action is peroxiso-
me proliferator activated receptor- (PPA-
R-) in fat. Alternatively it may have direct
actions on PPAR- in other tissues like
muscle and liver20. This is in agreement
with our finding that troglitazone decrea-
sed the glucose production in hepatocytes
acting directly in culture but only in rats
on sunflower-oil diet. It is important to
say that this effect of troglitazone was ob-
served in the total absence of insulin. It
was already shown that troglitazone re-
duced gluconeogenesis in the hepatocytes
obtained from fasted rats and not in those
from fed animals21. These results cannot
explain the differences in troglitazone ac-
tion in our two experimental groups. Any-
how, the troglitazone in the presence of
insulin totally normalized the glucose
production but again only in hepatocytes
obtained from rats on sunflower-oil diet.
Presumably insulin resistance in our two
experimental groups is not the same. Eti-
ological factors are different (saturated
and unsaturated fat). The mechanism of
insulin resistance could also be different,
as well as sensitivity to the therapeutic
action of troglitazone. Our results clearly
demonstrate that the result and success
of therapy of diabetes Type 2 is dependent
on the metabolic status of animals and on
diet.
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U^INCI TROGLITAZONA I INZULINA NA PROIZVODNJU GLUKOZE U
KULTIVIRANIM HEPATOCITIMA IZOLIRANIM IZ [TAKORA NA DIJETI
BOGATOJ MASTIMA
S A @ E T A K
Pove}ani unos masno}a, a posebno zasi}enih masti, dovodi do smanjenja inzulin-
skog u~inka. Cilj istra`ivanja je otkriti promjene u proizvodnji glukoze iz jetre u ovis-
nosti o masnoj dijeti i mogu}e direktne u~inke inzulina i troglitazona u hepatocitima.
Hepatociti su izolirani pomo}u kolagenaze i kultivirani 24 sata u M 199 mediju bez do-
datka seruma. U hepatocitima izoliranim iz {takora na visoko masnoj dijeti (nezasi}ene
masno}e) proizvodnja glukoze bila je 79% ve}a u usporedbi sa kontrolom i 139% ve}a
ako su bili na visoko masnoj dijeti (zasi}ene masno}e). Troglitazon je signifikantno sma-
njio proizvodnju glukoze u hepatocitima dobivenim iz {takora na masnoj dijeti sa neza-
si}enim masno}ama. Troglitazon je u prisutnosti inzulina u potpunosti normalizirao
proizvodnju glukoze ali opet samo u {takora koji su hranjeni na masnoj dijeti sa nezasi-
}enim masno}ama. Troglitazon je sam djelovao sli~no inzulinu, a osim toga pove}ao je
osjetljivost stanica na inzulin, ali samo ako su {takori bili na visoko masnoj dijeti sa ne-
zasi}enim masno}ama.
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